Loading...
XMADNTH
Market cap104mUSD
Dec 20, Last price  
1.67EUR
1D
-0.60%
1Q
-1.18%
Jan 2017
-64.84%
IPO
-66.53%
Name

Naturhouse Health SA

Chart & Performance

D1W1MN
XMAD:NTH chart
P/E
8.87
P/S
1.99
EPS
0.19
Div Yield, %
5.99%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
-10.40%
Revenues
50m
-3.81%
59,881,00095,731,00095,792,00097,815,00094,700,00087,289,00081,667,00055,081,00057,594,00052,403,00050,407,000
Net income
11m
+17.31%
8,544,00022,560,00022,860,00022,504,00019,855,00015,373,00013,257,0009,379,00013,361,0009,627,00011,293,000
CFO
21m
+195.20%
7,452,00024,871,00020,946,00016,034,00016,001,00020,095,00019,677,00014,580,00016,173,0007,097,00020,950,000
Dividend
Aug 29, 20240.081 EUR/sh

Profile

Naturhouse Health, S.A. operates in the nutrition and weight management industry in Spain, Italy, France, Poland, and internationally. The company sells food supplements that are made from natural extracts to facilitate the consumption of various nutrients; and foods and drinks, such as diet products for breakfast, snacks, and meal substitutes. It also offers cosmetics and body care products, including beauty products related to skincare during the slimming process comprising cellulite, firming products, etc.; and anti-ageing products. As of December 31, 2020, it operated through a network of 1,788 centers in 28 countries. The company sells its products through directly operated and franchised Naturhouse centers. The company was formerly known as Housediet, S.L.U. The company was founded in 1991 and is based in Madrid, Spain.
URL
https://www.naturhouse.com/
IPO date
Apr 09, 2015
Employees
208
Domiciled in
ES
Incorporated in
ES

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
50,407
-3.81%
52,403
-9.01%
57,594
4.56%
Cost of revenue
16,573
25,089
25,479
Unusual Expense (Income)
NOPBT
33,834
27,314
32,115
NOPBT Margin
67.12%
52.12%
55.76%
Operating Taxes
4,168
3,484
4,879
Tax Rate
12.32%
12.76%
15.19%
NOPAT
29,666
23,830
27,236
Net income
11,293
17.31%
9,627
-27.95%
13,361
42.46%
Dividends
(6,000)
(18,000)
(3,600)
Dividend yield
6.18%
19.00%
3.11%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
1,515
1,199
894
Long-term debt
6,697
5,335
3,564
Deferred revenue
Other long-term liabilities
1,641
4,189
3,228
Net debt
(29,174)
(16,207)
(30,490)
Cash flow
Cash from operating activities
20,950
7,097
16,173
CAPEX
(570)
(964)
(50)
Cash from investing activities
(459)
(5,218)
(4,268)
Cash from financing activities
(7,695)
(16,985)
(6,266)
FCF
35,077
20,284
29,031
Balance
Cash
27,098
14,775
27,250
Long term investments
10,288
7,966
7,698
Excess cash
34,866
20,121
32,068
Stockholders' equity
28,626
35,482
47,435
Invested Capital
9,881
13,609
7,998
ROIC
252.58%
220.58%
285.93%
ROCE
87.24%
80.25%
79.57%
EV
Common stock shares outstanding
59,949
59,949
59,949
Price
1.62
2.53%
1.58
-18.13%
1.93
24.52%
Market cap
97,118
2.53%
94,720
-18.13%
115,702
24.52%
EV
67,950
78,565
85,272
EBITDA
36,097
29,612
34,572
EV/EBITDA
1.88
2.65
2.47
Interest
616
206
100
Interest/NOPBT
1.82%
0.75%
0.31%